3.29
price up icon5.79%   0.18
 
loading

Lipocine Inc 주식(LPCN)의 최신 뉴스

pulisher
Nov 23, 2025

Lipocine Inc. (LPCN) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 23, 2025
pulisher
Nov 21, 2025

Lipocine reports ‘promising’ safety profile in Phase 3 trial of LPCN 1154 - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

Why hedge funds are buying Lipocine Inc. stockPortfolio Profit Report & Precise Trade Entry Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Can Lipocine Inc. stock sustain revenue growthJuly 2025 Weekly Recap & Community Consensus Stock Picks - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Lipocine Inc. stock outperform value stocksMarket Risk Report & Low Risk High Win Rate Stock Picks - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can Lipocine Inc. stock resist sector downturnsJuly 2025 Recap & AI Powered Market Trend Analysis - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Lipocine Inc. stock reacts to inflationary pressuresOptions Play & Free Growth Oriented Trading Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Smart tools for monitoring Lipocine Inc.’s price actionEarnings Summary Report & Community Driven Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Lipocine Inc. stock a safe buy before earningsQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Lipocine reports positive safety review for PPD treatment in phase 3 trial - Investing.com Nigeria

Nov 18, 2025
pulisher
Nov 18, 2025

Lipocine Announces Positive Interim Results for PPD Trial - TipRanks

Nov 18, 2025
pulisher
Nov 18, 2025

[8-K] Lipocine Inc. Reports Material Event | LPCN SEC FilingForm 8-K - Stock Titan

Nov 18, 2025
pulisher
Nov 18, 2025

Lipocine highlights promising interim safety profile in phase 3 trial of LPCN 1154 in postpartum depression (PPD) - MarketScreener

Nov 18, 2025
pulisher
Nov 18, 2025

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) - The Herald Journal

Nov 18, 2025
pulisher
Nov 17, 2025

HC Wainwright Issues Negative Forecast for Lipocine Earnings - Defense World

Nov 17, 2025
pulisher
Nov 16, 2025

Will Lipocine Inc. stock go up soonForecast Cut & Long-Term Growth Plans - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

HC Wainwright Cuts Lipocine (NASDAQ:LPCN) Price Target to $7.00 - Defense World

Nov 16, 2025
pulisher
Nov 15, 2025

Why analysts upgrade Lipocine Inc. stockJuly 2025 Earnings & Entry and Exit Point Strategies - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Lipocine price target lowered to $7 from $8 at H.C. Wainwright - MSN

Nov 15, 2025
pulisher
Nov 14, 2025

How Lipocine Inc. stock performs after earningsDollar Strength & Growth Oriented Trade Recommendations - newser.com

Nov 14, 2025
pulisher
Nov 13, 2025

Lipocine stock price target lowered to $7 at H.C. Wainwright on PPD trial timeline - Investing.com Nigeria

Nov 13, 2025
pulisher
Nov 13, 2025

Lipocine stock price target lowered to $7 at H.C. Wainwright on PPD trial timeline By Investing.com - Investing.com South Africa

Nov 13, 2025
pulisher
Nov 13, 2025

LPCN: Analyst Lowers Price Target While Maintaining Buy Rating | - GuruFocus

Nov 13, 2025
pulisher
Nov 13, 2025

Will a bounce in Lipocine Inc. offer an exitEarnings Risk Report & Weekly Watchlist for Consistent Profits - newser.com

Nov 13, 2025
$39.42
price up icon 0.77%
$31.75
price down icon 0.84%
$102.65
price up icon 2.31%
$96.28
price up icon 0.30%
biotechnology ONC
$322.75
price down icon 2.55%
$204.53
price down icon 0.07%
자본화:     |  볼륨(24시간):